Featured Research

from universities, journals, and other organizations

New Mouse Model Gives Clue To Muscle-wasting In Myotonic Dystrophy Type 1

Date:
February 14, 2008
Source:
Baylor College of Medicine
Summary:
A mouse bred to have the same genetic mutation as people with myotonic dystrophy provides important clues about the cause of muscle wasting in the disorder, the most common form of muscular dystrophy that begins in adulthood. Unlike previous mouse models of the disease, these animals have a genetic mutation that causes the muscle wasting that is the most devastating element of this inherited disorder, said one of the researchers, who is also a professor of pathology and molecular and cellular biology.

A mouse bred to have the same genetic mutation as people with myotonic dystrophy provides important clues about the cause of muscle wasting in the disorder, the most common form of muscular dystrophy that begins in adulthood, said researchers at Baylor College of Medicine in Houston.

Dr. Thomas C. Cooper and his colleagues from BCM and France described the new mouse in a report in the current online issue of the Proceedings of the National Academy of Science. Unlike previous mouse models of the disease, these animals have a genetic mutation that causes the muscle wasting that is the most devastating element of this inherited disorder, said Cooper, professor of pathology and molecular and cellular biology at BCM.

Genetic disease

Myotonic dystrophy occurs in as many as 1 in 8,000 people worldwide. Type 1 is by far the most common form. The most obvious symptoms are muscle wasting and weakness that can become life threatening. It is a genetic disease and can be inherited.

"We made our mutation as close to that which appears in people as is possible," said Cooper.

The mutation that causes muscular dystrophy involves a larger than normal series of repeats of the nucleotides C (cytosine), T (thymine) and G (guanine) in the end of the DMPK (dystrophia myotonica-protein kinase) gene. These large repeats make the product of the mutated DMPK gene toxic to cells.

Cooper and his colleagues made sure that the nucleotide repeats in the mouse gene occurred in the same area as the repeats in the human gene.

In this mouse, Cooper and his colleagues made the gene so that it remained dormant until the mouse reached adulthood. Then, when they turned it on, it caused rapid muscle wasting in as little as four weeks.

Alternative slicing

In studying the molecular attributes of these mice, Cooper and his colleagues found many features similar to those of people with the human form of myotonic dystrophy type 1. In this case, Cooper and his colleagues found alternative slicing events related to the CUG binding protein (CUGBP1), which has been previously shown important in myotonic dystrophy.

Alternative splicing is a key method by which the 25,000 to 30,000 human genes make the 100,000 or more proteins important to the functioning of the human body. For one gene to make different proteins, it has to alter the genetic message, choosing which coding parts of the gene called introns are included in the protein "recipe" used by the cell's protein-making machinery. In these mice, a mistake in the regulation of these alternative splicing events results in increased levels of the CUGBP1 protein, which indicates that this protein may play a role in the muscle wasting found in patients with myotonic dystrophy.

"This experiment tells us something about the different components in the mutation that you need to reproduce muscle wasting," said Cooper. "One of the subtle things we found in our mouse model is that there is a change in the expression of this one protein – the CUGBP1 protein – that is not seen in other mouse models. We found some genes regulated by this protein at the level of splicing and three of them were not regulated properly. When we looked at human patient samples, we saw that these three genes were also misregulated at the level of splicing. It looks as though our model is reproducing the events of the human disease."

Others who took part in this research include James P. Orengo and Drs. Dennis R. Mosier and G. Jackson Snipes of BCM and Pierre Chambon and Daniel Metzger of the Institute of Genetics and Molecular and Cellular Biology in Strasbourg, France.

Funding for this work came from the National Institutes of Health, the Muscular Dystrophy Association and the U.S. Department of Veterans Affairs.


Story Source:

The above story is based on materials provided by Baylor College of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Baylor College of Medicine. "New Mouse Model Gives Clue To Muscle-wasting In Myotonic Dystrophy Type 1." ScienceDaily. ScienceDaily, 14 February 2008. <www.sciencedaily.com/releases/2008/02/080213163202.htm>.
Baylor College of Medicine. (2008, February 14). New Mouse Model Gives Clue To Muscle-wasting In Myotonic Dystrophy Type 1. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2008/02/080213163202.htm
Baylor College of Medicine. "New Mouse Model Gives Clue To Muscle-wasting In Myotonic Dystrophy Type 1." ScienceDaily. www.sciencedaily.com/releases/2008/02/080213163202.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins